Saghmos Therapeutics
Greenwich, US · Founded 2016 · Delaware corporation
Founders & leadership
AK
Anna KazanchyanNamed on SEC filing
SC
Shalini CornelioNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 1 round · 2017
▶$3.5MraisedApr 2018 · 5 investors · PharmaceuticalsRule 506(b)
▶$3.5MraisedApr 2018 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anna KazanchyanExecutive Officer
- Shalini CornelioExecutive Officer
- Offering amount
- $7M
- Amount sold
- $3.5M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Saghmos Therapeutics raised?
- Saghmos Therapeutics has disclosed $3.5M raised across 1 round.
- Where is Saghmos Therapeutics headquartered?
- Saghmos Therapeutics is headquartered in Greenwich, US.